VNDA (STOCKS)
Vanda Pharmaceuticals Inc.
$6.920000
-0.500000 (-6.74%)
Prev close: $7.420000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mihael Hristos Polymeropoulos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $439.68M
- Employees
- 368
- P/E (TTM)
- -5.19
- P/B (TTM)
- 0.94
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.46 | $-1.35 | +0.8915 | +65.96% |
|
Sep 2025 (Q3)
|
$-0.38 | $-0.46 | +0.0824 | +17.82% |
|
Jun 2025 (Q2)
|
$-0.46 | $-0.36 | -0.0962 | -26.44% |
|
Mar 2025 (Q1)
|
$-0.50 | $-0.61 | +0.1086 | +17.84% |
Financial Statements
| Assets | $601.14M |
| Current Assets | $367.50M |
| Inventory | $2.04M |
| Other Current Assets | $365.45M |
| Noncurrent Assets | $233.64M |
| Fixed Assets | $2.46M |
| Other Non-current Assets | $231.18M |
| Liabilities | $135.14M |
| Current Liabilities | $117.87M |
| Wages | $8.75M |
| Other Current Liabilities | $109.12M |
| Noncurrent Liabilities | $17.27M |
| Equity | $466.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $466.00M |
| Liabilities And Equity | $601.14M |